skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Sponsorship Opportunities

The Informa Pharma Intelligence Awards bring together the brightest and best minds in pharma and biotech. With a captive audience of senior decision makers, the Awards offer a prime opportunity to amplify your organization’s message and generate new business.

Become a sponsor to:

  • Position your organization at the forefront of the industry, and strengthen relationships with the most prominent names in Japanese pharma and biotech
  • Enhance your industry reputation in your specific area of expertise
  • Raise awareness of your organization among our distinguished panel of judges
  • Take advantage of extensive branding opportunities across numerous marketing channels - pre, during and post Awards


With numerous high-level sponsorship opportunities available, from Headline Sponsor, Category Sponsor, to Social Media and Drinks Reception Sponsor, the Awards provide you with a platform to educate, engage and empower your most important audience.

Limited opportunities available. For more information on what’s available for 2022, download the sponsorship brochure or contact:

Christopher Keeling

Tel: +44 (0) 7917 647 859



Download Sponsorship Guide

Headline Sponsor




ICON plc is a world-leading healthcare intelligence and clinical research organisation, with over 38,000 employees in 93 locations in 46 countries around the world, headquartered in Dublin. We advance clinical research by providing outsourced development and commercialisation services to pharmaceutical, biotechnology, medical device, and government and public health organisations. Our services span the entire lifecycle of product development, from molecule to medicine, across a broad range of therapeutic areas. We develop new innovations, drive emerging therapies forward, and improve patient lives.







Avance Clinical is a premium full-service Contract Research Organisation (CRO) based in Australia providing high-quality clinical research services to the international drug development industry which brings innovative new drugs to patients. Avance Clinical has more than 260 staff and has backing from the private equity group, Riverside Company, to support global expansion plans.

Avance Clinical offers clinical project management, trial monitoring, regulatory support, safety reporting, scientific and medical writing, data management, statistical and pharmacokinetic services, and external clinical auditing. We operate to the highest standards of compliance required by global regulatory agencies such as the FDA to ensure acceptance of data for drug approvals.

Our clients are international biotech companies in their early phases of drug development that require fast, agile, and adaptive solution-oriented clinical research services. The company uses state-of-the-art technology, gold standard systems, and deep scientific expertise to provide clients with the most successful outcomes.

Avance Clinical delivers exceptional study approval rates through its understanding of the Australian regulatory environment and inhouse scientific and regulatory expertise. Our clients are predominantly from North America, Europe, and Asia.



CMIC stands for Current Medical Information Center. In 1992, Dr. Kazuo Nakamura founded CMIC as the first Contract Research Organization (CRO) in Japan. CMIC Group is currently the largest clinical CRO in Japan, providing comprehensive services in drug development, clinical trial and clinical site management, clinical to commercial GMP manufacturing, regulatory consulting and contract sales & marketing solutions. We can help pharmaceutical, biotech and medical device companies to enter Japan market, to conduct clinical trials in Asia, or to bridge your drug development and manufacturing needs between the US and Japan. CMIC Group has over 7,000 employees and 25 sites globally.